AusPAR: Insulin aspart (rys)
Australian Public Assessment Report
Device/Product Name
Fiasp; Fiasp Penfill; and Fiasp FlexTouch
Active ingredients
Insulin aspart (rys)
AusPAR Date
Published
Submission Number
PM-2018-05745-1-5
Submission Type
Extension of indications
Decision
Approved